Obesity News Bulletin

Unprecedented surge in applications for obesity medicine certification among U.S. physicians

The realm of obesity medicine is witnessing a remarkable influx of interest among U.S. physicians, showcased by a record-setting number of nearly 1,900 applicants aspiring to gain certification in this burgeoning field, as per recent figures released by the American Board of Obesity Medicine (ABOM). The forthcoming certification examination slated for October has garnered the participation of 1,889 physicians, portraying a significant ascent from the 1,001 candidates recorded in the previous year, a steep rise of 88.7%.

This amplified inclination towards obesity medicine certification among physicians parallels the soaring demand among patients for GLP-1 receptor agonist medications, namely Ozempic and Wegovy. The escalating appeal of these medications is underscored by the remarkable sales figure of Ozempic, which, as of August 2023, eclipsed $3 billion in the U.S. market.

Since its inception in 2012, the obesity medicine certification has been bestowed upon over 6,700 physicians. The profile of attendees for the upcoming October exam delineates a diverse representation, with 38% being internal medicine physicians and 30% specialising in family medicine. A prerequisite for appearing in the certification exam mandates physicians to accrue a minimum of 60 continuing medical education credits focusing on obesity.

The burgeoning interest in obesity medicine is also echoed in the sentiments shared by Dr. Judith Korner, MD, PhD, the board chair of ABOM, in a statement released on September 20. Dr. Korner emphasised that numerous diplomats have conveyed their pursuit of certification as a testament to their adeptness and knowledge in addressing obesity—a domain which often receives scant attention during their preceding medical instruction.

Dr. Korner further elucidated that the acknowledgment of obesity as a multifaceted chronic ailment, coupled with the progressive strides in devising efficacious treatment modalities, is fuelling the aspirations of physicians to render optimal care for individuals grappling with obesity. This, she believes, is the propelling force enticing a growing number of physicians towards this rapidly evolving medical frontier.
The establishment of ABOM in 2011 marked the genesis of a structured pathway for physicians to garner expertise in obesity medicine, and the current surge in applications embodies the expanding recognition and relevance of this medical specialty in contemporary healthcare paradigms.

The College of Contemporary Health, based in the United Kingdom, is also a pioneer in the field of education in obesity care and weight management, offering students from around the world certification in the field in the form of both postgraduate education and continuing professional development. Find our prospectus here to learn more.

Exercise hormone irisin emerges as potential therapeutic agent in Alzheimer’s research

In the relentless pursuit to find effective treatments for Alzheimer’s disease, researchers have spotlighted a potential new ally: the hormone irisin, which is generated during physical exercise. This revelation brings a beacon of hope, suggesting a potential new frontier in Alzheimer’s therapy.

According to a recent study carried out by a team at the Massachusetts General Hospital in Boston, the elevation of irisin levels, encouraged through physical exercise, showcases promising results in reducing the plaque and tau tangles that are trademarks of Alzheimer’s disease. The role of irisin had been previously linked to the regulation of glucose and lipid metabolism in adipose tissue and the acceleration of the conversion of white fat tissue to brown, a process that augments energy expenditure.

Before delving deeper into irisin’s impact on Alzheimer’s, the team had pioneered the development of 3D human cell culture models of the disease. These models played a pivotal role in understanding how irisin interacts with amyloid-beta, a significant player in the Alzheimer’s landscape, present in the brain.

Previous studies on murine models had affirmed the beneficial effects of physical exercise in diminishing amyloid-beta accumulations, albeit without understanding the precise mechanism. The fresh insights gleaned from this study illuminated that irisin’s influence in this context is closely tied to the enhancement of an enzyme known as neprilysin, which is proficient in degrading amyloid-beta.

Se Hoon Choi, one of the study’s authors, illuminated that treating with irisin led to a “remarkable reduction of amyloid-beta pathology,” an effect steered by the bolstered activity of neprilysin, which is secreted in higher quantities by brain cells called astrocytes, in response to irisin.

Notably, the researchers managed to pinpoint the pathway that prompts cells to amplify neprilysin levels, opening avenues for further exploration and therapy development. The endeavour now stood grounded on a robust foundation of understanding how irisin, once introduced into the bloodstream, can navigate its way to the brain, showcasing its potential utility as a therapeutic agent.

Furthermore, senior author Rudolph Tanzi noted that irisin could be the principal orchestrator behind exercise-induced escalations in neprilysin levels that are instrumental in alleviating the amyloid-beta burden in the brain. Tanzi underscored the significant implications of these findings, propelling irisin to the centre stage as a promising target for preventive and therapeutic strategies against Alzheimer’s disease.
This groundbreaking study, published in the renowned journal Neuron on September 8 2023, brings to light irisin’s pivotal role as a mediator, leveraging the natural, exercise-induced hormone to forge a path towards revolutionary Alzheimer’s treatments. It brings us a step closer to harnessing the potential of physical exercise at a molecular level in battling the devastating impacts of Alzheimer’s, thus offering a new ray of hope in medical science’s quest to conquer this debilitating disease.

Obesity linked to impairment of immune cells protecting against psoriasis

Obesity is more than just a condition associated with excess weight; it can also influence the immune system in ways that make the body more susceptible to certain diseases. Recent research has shed light on how obesity may impair immune cells that protect against inflammation associated with psoriasis, a common skin disorder. This newfound understanding could pave the way for new treatments for psoriasis, particularly for those who suffer from obesity.

Psoriasis, marked by an accumulation of dry, scaly skin patches, is found to be twice as prevalent in individuals with obesity as compared to those without. This connection between obesity and psoriasis has long been observed, but the underlying mechanisms have remained elusive.

Researchers at Emory University in Atlanta, Georgia, led by Chaoran Li, took up the challenge to explore the intersection between obesity, inflammation, and psoriasis. They specifically investigated regulatory T-cells, which play a crucial role in controlling inflammation. These cells maintain a delicate balance in the skin, offsetting pro-inflammatory immune cells. While obesity is known to increase inflammatory cells, its influence on regulatory T-cells was not well understood.

Li’s team conducted a detailed genetic analysis of regulatory T-cells in various organs of mice, including the skin, spleen, lungs, and lymph nodes. They identified a unique subset of these cells that were prevalent in the skin of the rodents. Interestingly, this group was also found to be abundant in human skin samples.

The research took a significant turn when scientists genetically modified mice to lack these specific cells. When they applied a cream that induces psoriasis-like symptoms, such as skin thickening, the modified mice’s skin became nearly 50% thicker in a week compared to those with the anti-inflammatory cells. This observation strongly suggested that these particular cells have a role in preventing psoriasis symptoms.

To delve into the relationship with obesity, another group of mice were fed a high-fat diet for 16 weeks. The skin of these mice with obesity displayed fewer regulatory T-cells and was more reactive to the psoriasis-inducing cream than the skin samples from mice on regular diets. This correlation between obesity and a decrease in anti-inflammatory immune cells that prevent psoriasis was a pivotal discovery.

These findings not only highlight obesity’s impairment of crucial immune cells but also hint that a high-fat diet may be a key factor in psoriasis and other skin-related inflammations. This insight opens up the possibility that dietary interventions could be a viable treatment option for psoriasis.

Another promising avenue explored by the researchers involved the drug pioglitazone, known to boost the activity of regulatory T-cells. It was found to reduce skin inflammation in mice with obesity. Intriguingly, pioglitazone is also a type 2 diabetes medication. Some studies have indicated that individuals with diabetes on this drug have a lower risk of psoriasis, raising the potential of the medication as a dual-purpose treatment.

However, the applicability of these findings to humans still requires validation. Li’s team plans to examine how this specific subset of cells varies in humans with both psoriasis and obesity compared to those with one or neither condition.

This research represents a significant stride in understanding the intricate relationship between obesity, immune function, and psoriasis. By unearthing the cellular mechanisms behind this connection, it could potentially lead to more targeted and effective treatment options for those struggling with psoriasis, especially in the context of obesity. It also emphasises the importance of a healthy diet and its impact on overall skin health.

Chronic inflammation may explain why some mothers with obesity struggle with low milk production

A recent study published in The Journal of Nutrition has revealed that inflammation in lactating mothers who have obesity may interfere with the transfer of circulating fatty acids to the mammary gland, resulting in low milk production.

Obesity is associated with chronic inflammation and is a risk factor for insufficient milk production. Inflammation-mediated enzymes have been shown to suppress the uptake of fatty acids from the blood by body tissues, leading to high blood lipid concentrations. Fatty acids are critical for supporting milk production in the mammary gland, and therefore, inflammation could negatively impact milk production through this pathway. To test this hypothesis, a team of researchers led by Rachel Walker, a USDA-funded post-doctoral fellow, analysed blood, milk fatty acid profiles, and inflammatory markers from lactating women. The study included 23 women with very low milk production despite frequent breast emptying, 20 with moderate milk production, and 18 exclusively breastfeeding controls.

The researchers found that mothers with very low milk production had significantly higher obesity and inflammatory biomarkers, lower proportions of long chain fatty acids in milk, and a disrupted association between blood and milk fatty acids, compared to those with moderate milk production and exclusively breastfeeding controls. While milk and blood fatty acids were strongly correlated in controls, this was not the case in the very low or moderate milk production groups. These findings support the hypothesis that inflammation and obesity disrupt the transfer of fatty acids from circulation to the mammary gland, potentially contributing to insufficient milk production in women with obesity.

The study suggests the need for further investigation into the transfer of fatty acids to milk and its relationship with milk volume. The findings are of significant importance as it has been known for decades that mothers with obesity are at an increased risk of shortened breastfeeding duration. This study provides important new evidence that physiological differences, such as chronic inflammation, may contribute to some mothers’ struggles with milk production.

When do trends of inactivity begin?

Physical activity is important for both the current and future health of children. For a long time a belief has been held that children are adequately active with a dramatic decline in behaviour beginning from later adolescence into adulthood. This decline is much more significant in girls then in boys. Based on this understanding, for many years adolescent physical activity has been targeted by both national and international organisations. However, there has been a recent suggestion that declines in activity begin earlier than adolescence.

A group of researchers from Glasgow set out to determine when exactly changes in activity take place. They used a UK longitudinal cohort study from North-East England with data on participants across eight years. In physical activity research, questionnaires have shown to be highly unreliable and inaccurate, but they are often what is used in cohort studies as they are low cost. In this cohort, objective data using accelerometers (electronic monitors that record activity patterns across the day) were used at four separate years, making it a valuable resource to look at changes over time.

The researchers revealed that all trajectories of activity behaviour declined from seven years of age with no indication of a difference by gender. This analysis proves earlier understanding wrong and provides a strong case that policy and intervention efforts should begin well before adolescence.

Antibiotic consumption and childhood obesity

A growing base of evidence suggests antibiotic use results in microbial disturbances in the gut. These disturbances in the microbiome may contribute to weight gain. In comparisons between individuals, it has been shown that those with obesity have a lower diversity of microbes in their gut. This research is supported by studies in animal models. In infancy, a baby’s microbiome is rapidly developing. It is thus suggested by some researchers that any antibiotic exposure in infancy may impede the establishment of the healthy gut microbiome and have lifelong metabolic consequences.

In a systematic review and meta-analysis, Miller and colleagues showed that the antibiotic use in infancy is indeed related to overweight and obesity in childhood. There were notable differences however by gender with boys appearing to be more affected by antibiotic use than girls.

The authors looked at multiple drugs finding that macrolides were most strongly related to increased obesity risk while narrow-spectrum drugs were not significantly associated. These researchers suggest in the fight against childhood obesity we need to examine antibiotic prescriptions and use across populations.

Assessment of dietary patterns, physical activity and obesity among older US adults

Obesity in older adults results in premature declines in physical and mental health and cognitive functioning. Evidence shows that the incidence of obesity and chronic diseases are higher in rural areas than in urban areas. Furthermore, more older adults are concentrated in these rural areas. There is limited understanding of the behavioural factors driving increases in obesity in older adults in rural communities. Specifically, if differences in dietary behaviour between rural and urban settings contribute to elevated obesity rates. A study recently published in in PLOS One set out to firstly assess rural-urban differences in obesity rates in older adults, and secondly the relationship with dietary patterns.

Researchers used census data in a sample of respondents aged 65 years of age and above from the USA. Regression models were utilized to investigate if rural-urban disparities in obesity, and associations with risk factors of fruit consumption, green vegetable consumption and physical activity. The results revealed, consistent with earlier evidence, that obesity rates were highest in rural areas. In these rural areas, fruit consumption was the lowest. A negative association between obesity and fruit and green vegetable consumption was observed in urban but not rural settings. These findings illustrate the importance of considering urban-rural status when developing obesity prevention programs and strategies. Interventions need to address the unique barriers experienced between the two settings.

Predictors of weight gain in school children

Childhood obesity is a growing public health concern given the rising prevalence rates observed in both developed and developing countries. There are a multitude of health-related consequences that worsen into adulthood. Current estimates demonstrate that about 25% of children are overweight or obese. Given that obesity tracks into adulthood understanding why and how it emerges in early life is critical to developing effective preventative efforts.

In the European Journal of Clinical Nutrition, a recent analysis explored predictors of BMI change, overweight and obesity in school children. This was conducted in a prospective manner using a cohort of Irish school children 6-10 years of age. Height and weight were assessed objectively and lifestyle factors through a questionnaire with parents. These measurements were assessed five years apart at baseline and follow-up. Logistical regression models were then run by the researchers to understand the associations.

Initial BMI was the main predictor of subsequent overweight and obesity in schoolchildren, followed by the socioeconomic status of the school. Schools in disadvantaged areas had higher rates of obesity. Alongside this processed food consumption, lower levels of participation in sport clubs and low fruit intake was associated with higher levels of obesity. These findings illustrate the need for programmes aimed at preventing obesity with a focus on early years and disadvantaged communities.

Access to green space plays a role in the development of diabetes

Socioeconomic characteristics of the urban environments and neighbourhoods are associated with rates of obesity and type 2 diabetes. Access to green space within an individual’s residential area has been shown to be beneficial for health and well-being however, there is limited understanding of the relationship with type 2 diabetes. The aim of this study in the BMJ Open was to investigate the relationship between green space, body mass index (BMI) and type 2 diabetes.

The study examined this relationship in adults (25-74 years of age) in a large German city through the Dortmund Health Study. Researchers used geographical information systems to develop three indicators of green space: proportion of green space, available recreation area per person and distance to the next park or forest. Through regression analyses researchers demonstrated no association between green space and BMI. However, a lack of green space and further distance from parks or forests resulted in increased incidence of type 2 diabetes. The results suggest the availability of green space is an important part of the residential environment playing a role in the development of type 2 diabetes. It is essential to consider the built environment individuals live in when developing prevention plans and actions.

Childhood obesity inequalities in Britain are increasing over time

Across most high-income countries in the world socioeconomic inequalities in childhood obesity have been well documented. However, it is not clear how they have changed over time. Using Britain as an example, this study published in The Lancet, investigated how socioeconomic inequalities in childhood and adolescent weight, height, and BMI have changed over time.

The analyses demonstrated that from 1953 to 2015 socioeconomic associated inequalities in childhood obesity emerged and widened, while height differences became narrower. In 2001, at age 11 a there was a difference of 1.40 kg at the 50th weight percentile whereas a difference of 4.88 kg was observed at the 90th weight percentile. This finding that relative socioeconomic inequalities in obesity are worsening is consistent with other cross-sectional evidence including the UK’s national measurement program.

These significant changes show the impact of social changes on child and adolescent growth and development. The increasingly obesogenic environments in societies disproportionately affects disadvantaged children. These findings illustrate that the numerous policy initiatives implemented in Britain since 1991 have been insufficient and ineffective.

As these inequalities continue to widen there is clearly a need for new approaches to reduce differences in rates of childhood obesity between advantaged and disadvantaged populations. These trends are similar in many countries globally. Without effective interventions, inequalities seen in childhood and adolescence will continue to widen further throughout adulthood with significant health consequences.

Obesogenic factors and environments contributing to rising rates of obesity in Mexican children

Mexico has one of the highest youth obesity rates worldwide currently at 34% of all children and adolescents. This problem is rapidly worsening in Mexico with drastic consequences. There is limited understanding of the factors driving the rapidly increasing rates in Mexico. An understanding of determinants is critical to developing interventions, health programs and policies to effectively take on the crisis.

A recent review in Global Health Action set out to compile, describe, and analyse dietary conditions, physical activity, socioeconomic status, and cultural factors that create and exacerbate an obesogenic environment among Mexican youth. The authors approached this through a narrative review conducted across scientific databases and governmental reports.

The findings revealed a multitude of contributing factors including reduced healthy meal options at public schools, high rates of sedentary lifestyles among adolescents, lack of open spaces and playgrounds, socioeconomic deprivation, false or misunderstood sociocultural traditional beliefs, misconceptions about health, a high percentage of overweight or obese adults, and low rates of maternal breastfeeding. The factors identified are exacerbating the obesity problem in this population. From this evidence it is apparent that the average Mexican child is surrounded by a multitude of obesogenic factors driving rising rates of obesity. Measures to control these factors is drastically needed to stop continuation of the escalating rates.

Acute and Chronic Effects of Exercise on Appetite, Energy Intake, and Appetite-Related Hormones

The simple equation for obesity is Energy out < Energy in. The simplest way of increasing our ‘Energy out’, is to exercise more. However, the benefits of exercise extend beyond just calories, and in fact, it’s thought that exercise can improve subjective and homeostatic mediators of appetite in directions associated with enhanced meal-induced satiety. The degree to which this effect exists in an individual is highly variable and difficult to predict. This review, published in Nutrients, seeks to understand how adiposity, sex, and habitual physical activity modulate exercise-induced appetite, energy intake, and appetite-related hormone responses.

The review found that changes in perceptions of appetite, energy intake, and macronutrient composition in response to acute and chronic exercise stimuli are not modulated by levels of body adiposity or sex. However, in individuals with higher levels of habitual physical activity, they may exhibit improved sensitivity of the appetite control system through better compensatory adjustments for the energy content and density of food.

Although not conclusive, this paper draws attention to the benefits of exercise and need for an improved understanding of the individual factors that modulate appetite, appetite-related hormones, and food intake. Responses to exercise may help to explain the individual variability in body weight changes, and to facilitate the development of more efficacious weight management interventions.